SEIFERT v. MYLAN PHARMACEUTICALS INC. et al
Donald Seifert |
MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LTD., MYLAN N.V. and JOHN DOES 1-100 |
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION |
1:2022cv06727 |
November 22, 2022 |
US District Court for the District of New Jersey |
Sharon A King |
Robert B Kugler |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. ยง 1332 Diversity-Product Liability |
Defendant |
Docket Report
This docket was last retrieved on November 28, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 7 MDL Court Notification Letter. (ssp, ) |
Filing 6 MDL Court Notification Letter. (ssp, ) |
Member Case Direct File on 11/8/2022, for MDL 2875 VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION. (ssp, ) |
For all Case Management Orders #click here (ssp, ) |
Judge Robert B. Kugler and Magistrate Judge Sharon A. King added. (mmb, ) |
Filing 5 Certified Copy of Transfer Order and docket received, Case transferred in from District of New York Western; Case Number 1:22-cv-00853. Original file certified copy of transfer order and docket sheet received. |
Remark - Motion to transfer/remand to Multidistrict court and supporting documents. This motion was filed in USDC pursuant to Panel Rule 6.2(a). Motion will be decided by Multidistrict Panel. (KM) |
Filing 4 MULTIDISTRICT LITIGATION CONDITIONAL TRANSFER ORDER to the District of New Jersey. Signed by John W. Nichols, Clerk of the Panel on 11/17/2022. (KM) |
Filing 3 MOTION to Stay by Mylan Pharmaceuticals Inc.. (Attachments: #1 Exhibit Ex. A Notice of Tag-Along from District Court, #2 Exhibit Ex. B (JPML Doc #758) Conditional Transfer Order No. 53 (CTO-53) (Seifert), #3 Exhibit Ex. C (JPML Doc #759) Briefing Schedule for Objections to Conditional Transfer Order No. 53 (CTO-53) (Seifert)(7752056.1))(Means, Kirstie) |
Case assigned to Hon. Lawrence J. Vilardo. Notification to Chambers of on-line civil case opening. (CGJ) |
Notice of Availability of Magistrate Judge: A United States Magistrate of this Court is available to conduct all proceedings in this civil action in accordance with 28 U.S.C. 636c and FRCP 73. The Notice, Consent, and Reference of a Civil Action to a Magistrate Judge form (AO-85) is available for download at #http://www.uscourts.gov/services-forms/forms. (CGJ) |
AUTOMATIC REFERRAL to Mediation The ADR Plan is available for download at #http://www.nywd.uscourts.gov/alternative-dispute-resolution.(CGJ) |
Filing 2 Corporate Disclosure Statement by Mylan Pharmaceuticals Inc. identifying Corporate Parent Viatris Inc. for Mylan Pharmaceuticals Inc... (Means, Kirstie) |
Filing 1 NOTICE OF REMOVAL by Mylan Pharmaceuticals Inc. from Erie County Supreme Court, case number 807194/2022. (Filing fee $ 402 receipt number ANYWDC-4719493), filed by Mylan Pharmaceuticals Inc.. (Attachments: #1 Civil Cover Sheet, #2 Certificate of Service)(Means, Kirstie) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.